TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Amount of pain medication needed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of placental chronic inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: scoring systems of neurological findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: hemodynamics during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Count of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate of identifying whether the model test is positive or negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in adherence with monetary incentives
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in adherence without monetary incentives
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of correct predictions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Resting State Functional Connectivity (RSFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Added sugars intake relationship to brain structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Added sugars intake relationship to brain function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fructose intake relationship to brain structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fructose intake relationship to brain function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of viral populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change From Baseline at Week 24 in Bilateral Nasal Polyp Score (NPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline at Week 24 in Nasal Congestion Symptom Severity Score (NCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean of implant insertion quantity (ISQ) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean of torque value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Standardized uptake value of 177Lu-TATE-RGD in normal organs and tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance of Hydration parameters (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of IMG-004
Endpoint domain: Adverse events/effects
Primary endpoint: Siewert classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: length of esophageal involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: invasive Disease-Free Survival (iDFS)
Endpoint domain: Mortality/survival
Primary endpoint: Change in SSRI-30 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum handgrip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caries lesion activity and severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in sum level EPA and DHA in plasma phospholipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete metabolic response rate (CMR rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers that exhibit significant change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical utility of 3D model in surgical planning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of Participants With Treatment-Emergent Adverse Events (TEAEs) in Healthy Volunteers
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants With Treatment-Emergent Adverse Events (TEAEs) in CHB patients
Endpoint domain: Adverse events/effects
Primary endpoint: Feeding Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CATS Score at Completion of Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Objective remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in intermuscular fat deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in skeletal muscle mitochondrial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of obstructive sleep apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone contour accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Surgical exposure time for recipient site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Presence of periodontopathogenic bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of distinct episodes of cytomegalovirus replication greater than 1000 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Duration of valganciclovir (VGC) Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Balanced life levels
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: General self-efficacy levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Psychological well-being levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in brachial arterial diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in brachial arterial flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of HBV DNA in Peripheral Blood Mononuclear Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Quantification of cf DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of ct DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of CD8+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Australian Canadian Osteoarthritis Hand Index version (AUSCAN)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Flanker task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Stroop task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Diagnostic accuracy of the DSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of ALVAC-HIV vCP205 compared to ALVAC-RG vCP65
Endpoint domain: Adverse events/effects
Primary endpoint: Antibody, humoral, and cellular immune responses from ALVAC-HIV vCP205
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety data on AIDSVAX B/B boosting
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity data on AIDSVAX B/B boosting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adherence rate to allocation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recurrence free survival (RFS) at 3 months
Endpoint domain: Mortality/survival
Primary endpoint: Recurrence free survival (RFS) at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Recurrence free survival (RFS) at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Recurrence free survival (RFS) at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Blood virome characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Internal training load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough sensitivity to exogenous ATP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laryngeal sensitivity to exogenous ATP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory response in the airways
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of activities of daily living function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of physical function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of sense of well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child's language development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine specific IgM antibody titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean change in total serum bilirubin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Knowledge questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Tele-Tx Intervention acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of disease progression of PrCa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of aggressiveness of PrCa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants with prespecified end of treatment outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strengths and Difficulties Questionnaire (SDQ) total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of medically attended LRTI due to RT-PCR-confirmed RSV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean IOP Reduction from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Changes in soluble mediators in Bronchoalveolar lavage (BAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in soluble mediators in Sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in non-invasive exhaled particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in cell analyzation in BAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in cell analyzation in Sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Satisfaction with occupational performance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Freedom from death or intervention resulting from valve dysfunction or the implant procedure at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Freedom from device-related Major Adverse Events (MAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Procedural success defined as the successful implant of the device resulting in MR severity of < moderate at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: creatine-quinase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hooper index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness of visceral adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Thickness of quadriceps muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Detection of inflammatory and cardio-circulatory biochemical biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in hearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and proportion of subjects with treatment emergent adverse events (TEAEs), AEs and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Stress urinary incontinence symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Composite end point of cardiovascular and cerebrovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ESKAPE Transmission Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Objective Response by investigator assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Program Adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in Program Competence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in student disruptive behavior problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in student prosocial behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Nostril apex height measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of etanercept administration
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the concentration-time curve of BI 1810631 in plasma (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration of BI 1810631 in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of hrHPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oxidative stress markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in markers of muscle damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in markers of liver function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Emesis and nausea severity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of life in gastric cancer survivors
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fugl-Meyer Assessment of upper extremity scores (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weekly reach by providers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: monthly reach by providers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ultrasonic image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Health Patterns
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Major Reintervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: body mass loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in anxiety & depression scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in anxiety and quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Relative difference in PaO2/FiO2 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of contacts tested for SARS-CoV2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of contacts identified with SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Clinical pregnancy rate of ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continued pregnancy rate of ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of SGTB among infertile women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intentions to adhere to recommended breast cancer screening strategies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Deciding whether to take preventative endocrine therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived risk of breast cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Motor Competence: KTK3+ Backward Balancing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Counter Movement Jump Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of key study activities
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of treatment failure
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of lesions characterized as positive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of hepatic steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Difference in US synovitis score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects achieving sPGA of 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects who experience adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Lateral nasal wall fracture type
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social problem-solving
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attitudes towards seeking mental help
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Food Waste Volume
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Treatment success based on clinical and radiographic examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global chest pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wound area reduction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of participants on prednisone
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cumulative prednisone dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Communication Confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Healed tympanic membrane perforations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative dose-intensity of protein supplement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from Target Lesion Failure
Endpoint domain: Adverse events/effects
Primary endpoint: Implicit effect value (D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life in cancer patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Self-efficacy of PWID Peer Health Worker
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Behavioral Intentions of Peer Health Worker
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Flourishing Scale (Well-Being)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain-Numerical Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants who complete study visits with drug challenge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of participants who complete EEG
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in blood flow of associated arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in temporal and masseter muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Differences in gamma intertrial coherence and power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Differences in power of neural oscillations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Differences in amplitude and latency of various EEG waves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Awareness of Physical Therapists about Sensory Integration therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: newborn stress level in white noise group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: newborn stress level in lullaby group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mother's comfort in white noise group
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mother's comfort in lullaby group
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing